Hema.to raises €3.6M Seed round
26 June 2023· Munich, Germany· health, diagnostics, ai, biotech, b2b, pure_software
The funding will be used to scale its decision support software for blood cancer in European laboratories and grow its team of software engineers and immunologists.
Investors
LeadElaia Partners
Also participating
High-Tech GründerfondsHeal Capital
About Hema.to
Stage
Seed
Headquarters
Munich, Germany
Founded
2021
Team Size
21–50
Sectors
healthdiagnosticsaibiotechb2bpure_software